NCT02069158View on ClinicalTrials.gov

Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Breast CancerNSCLCOvary CancerEndometrial CancerSmall Cell Lung Cancer (SCLC)Head and Neck (HNSCC)
Interventions
DRUG

PF-05212384

iv administrartion

DRUG

Paclitaxel

iv administration

DRUG

Carboplatin

iv administration

Trial Locations (1)

6500

Oncology Institute of Southern Switzerland (IOSI), Bellinzona

All Listed Sponsors
lead

Cristiana Sessa

OTHER

NCT02069158 - Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor | Biotech Hunter | Biotech Hunter